Country-Specific Compliance Queries

China’s National Medical Products Administration (NMPA) has intensified regulatory oversight on imported pharmaceuticals, medical devices, and cosmetics. With stricter inspections, documentation requirements, and compliance checks, many foreign companies face delays, rejections, or even bans—costing millions in lost revenue. This guide explains the latest NMPA enforcement trends, common pitfalls for importers, and proven strategies to maintain…

The Surprising Exceptions to Pharmacy Licensing Rules In the highly regulated world of pharmaceutical distribution, most professionals assume that a valid pharmacy license is always required to dispense medications. However, there exist several perfectly legal exceptions that allow medication distribution without full pharmacy licensure under specific circumstances. This comprehensive guide examines the little-known regulatory loopholes,…

The Saudi Food and Drug Authority (SFDA) has introduced updated regulations for 2025, bringing significant changes for distributors and manufacturers in the Middle East. These rules impact product labeling, barcode compliance, and import requirements—yet many businesses remain unaware of critical updates, risking fines, shipment delays, and market access issues. This article breaks down the key…

Obtaining a license from the South African Health Products Regulatory Authority (SAHPRA) is a crucial step for pharmaceutical and medical device companies looking to operate in South Africa. However, wait times of 6 to 18 months remain a significant bottleneck, delaying access to market and impacting revenue. With new 2025 regulatory updates coming into effect,…

Bringing therapeutic goods into the Australian market requires more than just a quality product—it demands full compliance with the country’s regulatory framework. Whether you are an importer, manufacturer, or distributor of medicines, medical devices, or health supplements, aligning with the standards set by the Therapeutic Goods Administration (TGA) is essential. Non-compliance not only risks delays…